These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Generalized lipodystrophy. Singh S; Marwaha RK; Padmini P; Das KM; Sialy R Indian Pediatr; 1988 Apr; 25(4):377-80. PubMed ID: 3225047 [No Abstract] [Full Text] [Related]
26. Lipoatrophy associated with the use of insulin analogues: a new case associated with the use of insulin glargine and review of the literature. Holstein A; Stege H; Kovacs P Expert Opin Drug Saf; 2010 Mar; 9(2):225-31. PubMed ID: 20001763 [TBL] [Abstract][Full Text] [Related]
27. Growth hormone axis treatments for HIV-associated lipodystrophy: a systematic review of placebo-controlled trials. Sivakumar T; Mechanic O; Fehmie DA; Paul B HIV Med; 2011 Sep; 12(8):453-62. PubMed ID: 21265979 [TBL] [Abstract][Full Text] [Related]
28. A case of Lipoatrophic diabetes. Griffiths HJ; Rossini AA Radiology; 1975 Feb; 114(2):329-30. PubMed ID: 1110998 [TBL] [Abstract][Full Text] [Related]
31. Lipodystrophy, a variant of lipoatrophic diabetes. Steinberg T; Gwinup G Diabetes; 1967 Oct; 16(10):715-21. PubMed ID: 6054345 [No Abstract] [Full Text] [Related]
32. A severe case of lipoatrophy due to human insulin and insulin analogs in a patient with diabetes: is an immunological mechanism involved? Cabrera-Freitag P; Escalada J; Goikoetxea MJ; Laguna S; Sanz ML; Gastaminza G J Investig Allergol Clin Immunol; 2011; 21(5):417-9. PubMed ID: 21905513 [No Abstract] [Full Text] [Related]
33. Dysregulation of insulin-like growth factors in a case of generalized acquired lipoatrophic diabetes mellitus (Lawrence Syndrome) connected with autoantibodies against adipocyte membranes. Hübler A; Abendroth K; Keiner T; Stöcker W; Kauf E; Hein G; Stein G Exp Clin Endocrinol Diabetes; 1998; 106(1):79-84. PubMed ID: 9516065 [TBL] [Abstract][Full Text] [Related]
34. LIPOATROPHIC DIABETES. ISOLATION AND CHARACTERIZATION OF AN INSULIN ANTAGONIST FROM URINE. LOUIS LH; CONN JW; MINICK MC Metabolism; 1963 Oct; 12():867-86. PubMed ID: 14068079 [No Abstract] [Full Text] [Related]
35. Partial lipodystrophy with renal disorder. Saraçlar Y; Tinaztepe B; Coruh M; Erkoçak D Turk J Pediatr; 1972 Jan; 14(1):27-34. PubMed ID: 16295091 [No Abstract] [Full Text] [Related]
36. [Morphofunctional characteristics of the ovaries in generalized lipodystrophy syndrome]. Bronshteĭn ME; Letova EK; Starkova NT; Pishulin AA; Golubeva IV Sov Med; 1988; (5):102-6. PubMed ID: 3062801 [No Abstract] [Full Text] [Related]
37. [Lipoatrophic diabetes. A case description]. Bozhadzhieva E; Konstantinov N; Rachev R; Koev D; Chankova P Vutr Boles; 1973; 12(1):130-3. PubMed ID: 4351186 [No Abstract] [Full Text] [Related]
38. Letter: Management of lipoatrophic diabetes. Senior B; Gellis SS N Engl J Med; 1975 Jun; 292(23):1243. PubMed ID: 1128582 [No Abstract] [Full Text] [Related]
39. Lipodystrophy in patients with juvenile dermatomyositis--evaluation of clinical and metabolic abnormalities. Huemer C; Kitson H; Malleson PN; Sanderson S; Huemer M; Cabral DA; Chanoine JP; Petty RE J Rheumatol; 2001 Mar; 28(3):610-5. PubMed ID: 11296968 [TBL] [Abstract][Full Text] [Related]